Results 211 to 220 of about 757,384 (292)

Alternative MYB Promoter Activity Is a Potential Prognostic Biomarker in Head and Neck Adenoid Cystic Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background Adenoid cystic carcinoma (ACC) is an aggressive therapy‐resistant head and neck cancer with a high frequency of local recurrences and distant metastases. Activation of the MYB gene, encoding an oncogenic master transcription factor, is the key genomic hallmark of ACC and a potential therapeutic target. Here, we have investigated the
Fredrik Jäwert, André Fehr, Marta Persson, Adel K. El‐Naggar, Göran Stenman, Mattias K. Andersson   +5 more
wiley   +1 more source

Retrotransposition of a yeast group II intron occurs by reverse splicing directly into ectopic DNA sites

, 2001
Lorna M. Dickson, Hon-Ren Huang, Lu Liu, Manabu Matsuura, Alan M. Lambowitz, Philip S. Perlman   +5 more
openalex   +1 more source

Principles of 3′ splice site selection and alternative splicing for an unusual group II intron from Bacillus anthracis [PDF]

, 2004
Aaron R. Robart, NANCY KRISTINE MONTGOMERY, Kimothy L. Smith, Steven Zimmerly   +3 more
openalex   +1 more source

Control of branch-site choice by a group II intron

, 2001
Van Trung Chu
openalex   +2 more sources

High-affinity binding site for a group II intron-encoded reverse transcriptase/maturase within a stem–loop structure in the intron RNA [PDF]

, 2004
Kazuo Watanabe, Alan M. Lambowitz
openalex   +1 more source

CRS1, a Chloroplast Group II Intron Splicing Factor, Promotes Intron Folding through Specific Interactions with Two Intron Domains [PDF]

, 2004
Oren Ostersetzer, Amy Cooke, Kenneth P. Watkins, Alice Barkan   +3 more
openalex   +1 more source

An obligate intermediate along the slow folding pathway of a group II intron ribozyme [PDF]

, 2005
Linhui Julie Su
openalex   +1 more source

TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study

International Journal of Cancer, Volume 157, Issue 3, Page 534-548, 1 August 2025.
What's new? Tumor necrosis factor (TNF) can promote tumor resistance to immune checkpoint inhibitors (ICIs), which are now the standard treatment for advanced melanoma patients. Here, in an advanced melanoma patient cohort, TNF was investigated for a possible predictive relationship with ICI response. Assessments show that after 12 weeks of ICI therapy,
Mathieu Virazels, Amélie Lusque, Stéphanie Brayer, Matthieu Genais, Carine Dufau, Jean Milhès, Thomas Filleron, Cécile Pagès, Vincent Sibaud, Laurent Mortier, Olivier Dereure, Maha Ayyoub, Amandine Fabre, Nathalie Andrieu‐Abadie, Vera Pancaldi, Céline Colacios, Nicolas Meyer, Bruno Ségui, Anne Montfort   +18 more
wiley   +1 more source

Unusual Group II Introns in Bacteria of the Bacillus cereus Group [PDF]

, 2005
Nicolas J. Tourasse, Fredrik B. Stabell, Lillian Reiter, Anne‐Brit Kolstø   +3 more
openalex   +1 more source

The mitochondrial DNA copy number and ovary‐related reproductive disorders: A bidirectional two‐sample Mendelian randomization study

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 112-120, April 2025.
Abstract Objective In the present study, a bidirectional two‐sample Mendelian randomization approach was utilized to explore potential causal relationships between mitochondrial DNA copy number (mtDNA‐CN) and ovary‐related reproductive disorders (ORRDs), including ovarian dysfunction, ovarian cyst, polycystic ovary syndrome (PCOS), premature ovarian ...
Ke Peng, Xiao Han, Congquan Wu, Qiaowen Lu, Shujun Gao   +4 more
wiley   +1 more source